Antisense & RNAi Therapeutics Market 2018 Global Share, Trends, Demand, Challenges and Opportunities Research Report Forecast to 2023

Wiseguyreports.Com Added New Market Research Report On -“Antisense & RNAi Therapeutics Market 2018 Manufacturers, Applications and Future Demand Forecast to 2023 ”.

Pune, India - September 5, 2018 /MarketersMedia/ —

Global Antisense & RNAi Therapeutics Market

WiseGuyRerports.com Presents “Global Antisense & RNAi Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023” New Document to its Studies Database. The Report Contain 152 Pages With Detailed Analysis.

Description

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene "off".

Scope of the Report:

This report studies the Antisense & RNAi Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antisense & RNAi Therapeutics market by product type and applications/end industries.

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/3370710-global-antisense-rnai-therapeutics-market-2018-by-manufacturers

 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antisense & RNAi Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Glaxo Smith Kline

Sanofi Aventis / Genzyme

Isis Pharmaceuticals/ Ionis Pharmaceuticals

Arbutus Biopharma Ltd.

Silence Therapeutics

Bio-Path Holdings Inc.

Calando Pharmaceuticals

ICo Therapeutics

Quark Pharmaceuticals

Rexhan Pharmaceuticals

Biomarin/Prosensa

Regulus Therapeutics

Rxi Pharmaceuticals

Silenseed

Dicerna Pharmaceuticals

Sirnaomics Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

RNA interference

SiRNA

MiRNA

Antisense RNA

Market Segment by Applications, can be divided into

Oncology

Cardiovascular

Renal

Neurodegenerative

Respiratory

Genetic

Infectious Diseases

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3370710-global-antisense-rnai-therapeutics-market-2018-by-manufacturers

 

Table of Contents -Major Key Points

1 Antisense & RNAi Therapeutics Market Overview

1.1 Product Overview and Scope of Antisense & RNAi Therapeutics

1.2 Classification of Antisense & RNAi Therapeutics by Types

1.2.1 Global Antisense & RNAi Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Types in 2017

1.2.3 RNA interference

1.2.4 SiRNA

1.2.5 MiRNA

1.2.6 Antisense RNA

1.3 Global Antisense & RNAi Therapeutics Market by Application

1.3.1 Global Antisense & RNAi Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Renal

1.3.5 Neurodegenerative

1.3.6 Respiratory

1.3.7 Genetic

1.3.8 Infectious Diseases

1.4 Global Antisense & RNAi Therapeutics Market by Regions

1.4.1 Global Antisense & RNAi Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Antisense & RNAi Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Glaxo Smith Kline

2.1.1 Business Overview

2.1.2 Antisense & RNAi Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi Aventis / Genzyme

2.2.1 Business Overview

2.2.2 Antisense & RNAi Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals

2.3.1 Business Overview

2.3.2 Antisense & RNAi Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Arbutus Biopharma Ltd.

2.4.1 Business Overview

2.4.2 Antisense & RNAi Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Silence Therapeutics

2.5.1 Business Overview

2.5.2 Antisense & RNAi Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

 ……..CONTINUED

 

Contact Info:
Name: Norah Trent
Email: [email protected]
Organization: WiseguyReports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/antisense-rnai-therapeutics-market-2018-global-share-trends-demand-challenges-and-opportunities-research-report-forecast-to-2023/402956

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 402956